In addition, pterostilbene treatment blocks the progression of prostatic intraepithelial neoplasia (PIN) and adenocarcinoma in xenografts and transgenic mouse models by inhibiting MTA1 expression and signaling [12,30], suggesting superior pharmacological potency for resveratrol’s natural analogs with improved pharmacokinetics. The gene discussed is MTA1; the disease is adenocarcinoma.